ABSTRACT
F-T807 pharmacokinetics in human subjects using dynamic PET imaging and metabolite-corrected arterial input functions. Methods: Nine subjects (4 control, 3 with history of TBI, 2 mild cognitive impairment (MCI) due to suspected AD) underwent dynamic PET imaging for up to 120 minutes after bolus injection of 18 F-T807 with arterial blood sampling. Total volume of distribution (V T ) was estimated using compartmental modeling (one-and two-tissue configurations) and graphical analysis techniques (Logan and MA1 regression methods). Reference region-based methods of quantification were explored including Logan distribution volume ratio (DVR) and static standardized uptake value ratio (SUVR) utilizing the cerebellum as a reference tissue. Results: Percent unmetabolized 18 F-T807 in plasma followed a single exponential with T 1/2 of 17.0±4.2 minutes. Metabolite corrected plasma radioactivity concentration fit a bi-exponential (T 1/2 : 18.1±5.8; 2.4±0.5 minutes). 18 F-T807 in gray matter peaked quickly (SUV >2 at ~5 minutes). Compartmental modeling resulted in good fits and the two-tissue model with estimated blood volume correction (2Tv) performed best, particularly in regions with elevated binding. V T was greater in MCI subjects than controls in the occipital, parietal, and temporal cortices as well as the posterior cingulate gyrus, precuneus, and mesial temporal cortex. High focal uptake was found in the posterior corpus callosum of a TBI subject. Plots from Logan and MA1 graphical methods became linear by 30 minutes, yielding regional estimates of V T in excellent agreement with compartmental analysis and providing high quality parametric maps when applied in voxelwise fashion.
Reference region based approaches including Logan DVR (t*=55 min) and SUVR (80-100 min interval) were highly correlated with DVR estimated using 2Tv (R 2 =0.97, p<0.0001). Conclusions: 18 F-T807 showed rapid clearance from plasma and properties suitable for tau quantification with PET. Furthermore, simplified approaches utilizing DVR (t*=55 minutes) and static SUVR (80-100 minutes) with cerebellar reference tissue were found to correlate highly with compartmental modeling outcomes.
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INTRODUCTION
The tubulin-associated unit (or tau) is a naturally occurring protein that is integral in providing the white matter microtubule support structure. When impaired, tau proteins can abnormally hyperphosphorylate to form paired helical filaments and eventually insoluble aggregates (1, 2) . These neuronal changes are believed to cause decline in neuronal communication and eventual cell death. Tau pathology is a key hallmark in Alzheimer's disease (3) and traumatic brain injury (4, 5) . Recently, much effort has been placed in the development of PET radiotracers for in vivo quantitation of tau (6) . Optimal radiotracer characteristics for quantification of tauopathies include selectivity for tau, low nonspecific uptake, high brain penetration, fast clearance from plasma, minimal brain penetrating radioactive metabolites, and minimal defluorination for 18 F-labeled compounds. Several PET radiotracers are currently in use. 18 F-FDDNP showed promise initially, but binding was found to be non-specific (7) . In vivo imaging with [ 11 C]PBB3 (8) resulted in a radioactive metabolite was found to enter the brain complicating quantification of tau pathology (9) . A series of compounds developed by Okamura and colleagues are showing potential. Earlier versions, THK5105 and THK5117, had relatively high levels of white matter uptake, however, the most recent compound, THK5351, is reported to exhibit less white matter retention and promising kinetics (10, 11) . Two other compounds were developed by Siemens namely 18 F-T807 (12,13) (also known as 18 F-AV1451) and 18 F-T808 (14) . 18 F-T808 demonstrated high bone uptake suggestive of defluorination (15) . 18 F-T807 showed favorable PET imaging properties and imaging studies showed 18 F-T807 uptake tracked well with expected tau pathology distribution throughout the stages of Alzheimer's disease (12) . Due to the difficult synthesis of 18 F-T807 using methods initially described, our group developed a concise radiosynthesis appropriate for production on commercially available automated synthesis modules expanding the access of 18 
F-T807 (16).
Binding of 18 F-T807 in postmortem brain tissue from a range of neurological conditions has been assessed (17) and research utilizing 18 F-T807 for in vivo imaging has been active (18) , however a full characterization of the in vivo pharmacokinetic profile and determination of appropriate quantification methods has yet to be performed. Therefore, the goal of this work was to evaluate the pharmacokinetics of 18 F-T807 using dynamic PET imaging data and arterial input functions corrected for radiometabolites. In subjects demonstrating a wide range of expected tau pathology including healthy controls, subjects with MCI, and subjects with a history of traumatic brain injury, we performed compartmental modeling using arterial input functions. With the compartmental modeling estimates of by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from 4 total volume of distribution (V T ) as a gold standard, we then compared simplified approaches for estimation of V T and reference region based methods for quantitation of 18 F-T807 uptake.
METHODS

Subjects
As shown in table 1, nine subjects were included in this work consisting of 4 healthy controls absent neurological conditions, 2 with mild cognitive impairment (MCI), and 3 with a history of TBI (2 due to automotive accidents and 1 former professional football player with history of concussion). The study has been approved by the institutional review board at Massachusetts General Hospital, and all subjects signed an informed consent form.
--Insert Table 1 here-
Imaging Procedures
Magnetic Resonance Imaging
MRI procedures were performed for acquisition of a structural T1 weighted magnetization-prepared rapid gradient-echo (MPRAGE) (19) using a 3T Tim Trio (Siemens Medical Systems, Erlangen, Germany). The 3D acquisition used the following parameters: repetition time/echo time/inversion time, 2100/2.89/1100 ms, 12° flip angle, 1 mm slice thickness, matrix size 256 x 224.
Positron Emission Tomography
18
F-T807 was synthesized as previously described (16). Imaging was performed using an ECAT EXACT HR+ (CTI/Siemens, Knoxville, Tennessee, United States) in 3D acquisition mode. Emission data collection was initiated with the bolus injection of 121-196 MBq of 18 F-T807. Time bins were 6x10, 8x15, 6x30, 8x60, 8x120, and 6x300 seconds for the first 60 min, at which time the subjects were allowed a brief break and then repositioned on the scanner for collection of emission data from 75 up to 120 min as 9x300 sec frames. Six minute transmission scans were acquired just prior to administration of 18 F-T807 and immediately following the end of emission data acquisition for attenuation correction of PET images in the first and second scan blocks, respectively. 
Data Processing And Analysis
Image Processing
Dynamic PET sinograms were reconstructed using filtered backprojection while applying corrections for scatter, attenuation, deadtime, random coincident events, and scanner normalization. Final reconstructed images had voxel dimensions of 128 x 128 x 63 and voxel sizes of 2.06 x 2.06 x 2.42 mm. Motion correction was effected through frame-by-frame rigid body registration using a least squares algorithm with Levenberg-Marquardt optimization as described in (20) .
Dynamic PET images from session two were summed and rigidly coregistered to summed images from the pre-break imaging session (part one). To derive the transformation matrix, the dynamic PET images (summed from 1 to 10 minutes after 18 F-T807 injection) were rigidly coregistered to the structural MPRAGE image and the MPRAGE itself was transformed into standard MNI space (21) using affine registration followed by nonlinear warping (FLIRT and FNIRT in FSL (22)). The combined transformation matrix was then applied inversely on MNI and Harvard-Oxford atlases (FSL) in order to warp the atlas based regions of interest (ROIs) into native PET space for extraction of radioactivity time activity curves (TACs). ROIs surveyed in this work are described in Supplemental Table 1 and shown in Supplemental Figure 1 . To facilitate direct visual comparison between subjects, the PET images shown in the figures were transformed into MNI space using the derived combined transformation matrix.
Arterial Input Function
Whole blood (WB) and plasma time activity curves were obtained by linear interpolation of radioactivity concentrations (kBq/cc) measured from the arterial blood samples. Radiometabolite analysis was performed using our automated column switching radio-high performance liquid chromatography (radioHPLC) system (23, 24) . In short, arterial plasma was injected onto the column switching radioHPLC and initially trapped on a catch column by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from 6 (Waters Oasis HLB 30 μm) using mobile phase consisting of 99:1 H 2 O:MeCN at 1 mL/min (Waters 515 pump).
After four minutes, the catch column was backflushed with 75/25 0.1 M ammonium formate/MeCN at 1 mL/min (second Waters 515 pump) and directed onto a Waters XBridge BEH C18 (130 Å, 3.5 μm, 4.6 mm x 100 mm) analytic column. Eluent was collected in 1 min intervals and subsequently assayed for radioactivity using a Wallac Wizard 1470 gamma counter. After background radioactivity subtraction, radioactivity eluting in the 18 F-T807 peak was divided by the total activity and multiplied by 100% for calculation of percent parent in plasma (%PP).
Standardized uptake value (SUV) time courses of radioactivity in whole blood were generated for intersubject comparison by correcting absolute radioactivity concentrations (C [kBq/ml]) for subject body weight (BW [kg]) and injected dose (ID [MBq]): SUV=C/(ID/BW). All subjects underwent arterial sampling for measurement of radioactivity concentration, but due to technical problems, metabolite analysis was not performed in two subjects (S7, S8). Because metabolite analysis was not performed in two subjects, %PP time course for all subjects was fit to a single exponential decay to generate a groupwise %PP(t). Arterial input functions of 18 F-T807 radioactivity concentration in plasma were generated by correcting plasma radioactivity concentration for 18 F-T807 metabolism using the groupwise %PP(t) % /100%. Finally, 18 F-T807 arterial SUV time courses were generated for intersubject comparisons.
Compartmental Modeling With Plasma Input Functions
Compartmental modeling was performed, using in-house developed software (MatLab), for estimation of total volume of distribution V T and other kinetic parameters using C P (t) as the input function. Analyses were implemented on a regional basis using the conventional one-and two-tissue compartment models with a fixed vascular fraction 0.07 (1T, 2T) or a variable (1Tv, 2Tv) considered an additional parameter (25) . For completeness, two-tissue compartment models with irreversible binding (2T-irrev, 2Tv-irrev) -i.e., with the binding dissociation rate constant k 4 set to zero -were also examined.
For models with reversible binding, the outcome of primary interest was the macroparameter V T, the total volume of distribution, reflecting the equilibrium ratio of radiotracer concentration in the tissue vs. plasma (25) . For one-tissue models, the total volume of distribution is expressed in terms of estimated kinetic parameters by V T =K 1 /k 2 ; for two-tissue models, the relationship is given by V T =(K 1 /k 2 )(1+k 3 /k 4 ).
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Graphical Analysis With Plasma Input Functions
Graphical methods with plasma input functions are alternative techniques for estimation of V T in which linear regression is applied to an integral transformation of the measured dynamic data. We investigated Logan graphical method (26) and multilinear analysis 1 (MA1) (27) in this work. The optimal choice for the cutoff time t* was assessed empirically by repeating analyses for a range of t* values (20 to 110 minutes in 5 minute increments) and then assessing the time stability of V T estimates as well as visually examining the quality of the resulting line fits to determine the earliest cutoff time that was applicable for all subjects and regions measured.
Reference Region Based Analyses
Reference region based analyses of 18 F-T807 uptake were performed using the cerebellum (excluding the vermis) as a reference tissue. Distribution volume ratio (DVR) (equivalent to V T /V ND , assuming a valid reference tissue) was estimated using the Logan graphical method with reference region input function (28) . The optimal t* was determined as for the plasma Logan method by systematically varying the cutoff time and assessing linearity of the transformed data and stability of resulting DVR estimates.
The most simplified analysis method surveyed in this work was the SUVR of radioactivity concentration in a tissue region divided by the radioactivity concentration in the reference tissue. The cerebellum was again used as the reference tissue and SUVR was calculated from PET data acquired 80-100 minutes post-injection (SUVR 80-100 ).
Estimates of Logan DVR and SUVR were compared to equivalents of DVR from compartmental modeling with arterial inputs, namely .
Parametric Mapping
Dynamic PET images were smoothed by application of a 3 mm (FWHM) Gaussian filter. Logan analysis with plasma input were then applied in a voxel-by-voxel fashion to produce parametric maps of to allow a comparison with voxelwise parametric images generated using the Logan method with reference tissue input and static SUVR 80-100 .
Statistical Analysis
The goodness of fit for alternative compartmental models was compared within each data set using the Akaike information criterion ln / 2 , where n is the number of time frames, RSS is the residual sum of squares and k is the number of model parameters (29) . We utilized AIC weights to assign to each evaluated model the probability that that particular model gave the highest quality fit to the data. Weights were calculated as 
RESULTS
Imaging Procedures
PET and MR imaging procedures were performed in nine subjects from three status groups. Subject information is shown in Table 1 . The mean and standard deviation of the administered mass of 
Radioactivity In Arterial Blood
WB to plasma radioactivity concentration rapidly reached equilibrium averaging 0.98 ± 0.04 by 1 minute post injection as shown in Figure 1 .A. WB radioactivity time course showed consistency across subjects as shown in by
F-T807 radioactivity concentration time course in plasma is shown in Figure 1 .F. After five minutes post injection, the average metabolite-corrected plasma data were described well by a biexponential function (T 1/2 s = 2.4±0.5 and 18.1±5.8 minutes). After 10 minutes, the coefficient of variation (CV) in 18 F-T807 SUV in plasma across subjects was 17±3.5%. No differences in metabolite corrected plasma SUV were discernible between control subjects, subjects with a history of TBI, and MCI subjects.
--Insert Figure 1 here--
Region Of Interest Analysis
Peak SUV in gray matter averaged 2.4 ± 0.27 and was greater than 2 for all subjects. In white matter, peak SUV averaged 1.92 ± 0.17 for all subjects. Shown in Figure 2 are regional TACs from different brain regions for a representative control and two subjects demonstrating tau pathology. For the control subject, TACs had relatively homogeneous kinetics and converged to similar values by about 40 minutes. For the two subjects demonstrating tau pathology, TACs showed regionally enhanced uptake and greater inter-region heterogeneity in kinetics.
--Insert Figure 2 here-- Figure 2D shows cerebellar TACs for all subjects. The CB exhibited fast wash-in of radioactivity with high initial peak SUV (≥2) and rapid clearance (SUV <1 by 60 minutes). SUV values reached reasonable convergence by about 60 minutes. As observed in Figure 2D , subjects with a history of TBI exhibited somewhat reduced peak SUV compared to the control and MCI subjects.
Fits to regional TACs for the 2Tv models are shown in Figure 2A -C (fits for 1Tv models are shown in Supplemental Figure 2) . In MCI subjects, high preference for the 2Tv reversible model was observed (AIC weight,median =1). In control subjects, preference for the 2Tv reversible model was maintained with AIC weight,median =0.73. Interestingly, for the TBI subjects, model preference seemed to shift towards the 2Tv irreversible model, with AIC weight,median =0.05 for the reversible and AIC weight,median =0.48 for the irreversible model. The 2Tv reversible model was selected as the compartmental method of choice because it provided good fits in all data sets (notably including those showing high uptake), was statistically preferred in a majority of data sets, and provides an outcome consistent with our Table 2 Cerebellum showed lowest variability in V T (4.1±0.5; CV=11.8%) despite larger variation in SUV (see Figure 2D and text earlier in this section). No significant differences in cerebellar V T , K 1 , or k 2 were found between the subject groups. Cerebellar K 1 was stable at 0.26 ± 0.06 ml·min ).
--Insert Figure 3 here--Logan (26) and MA1 (27) graphical methods resulted in estimates of V T highly correlated with those from 2Tv. The Logan plot for one subject with a range of uptake is shown in Figure 3B , Logan DVR, and SUVR 80-100 maps generated using the CB as a reference region are shown in Figure 6 for a control subject, one subject who had been in a car accident approximately 10 years prior to imaging with 18 F-T807, and two MCI subjects. Also displayed is the subjects MPRAGE image in standardized space of the same slice for localization. Overall features are comparable for the alternative PET analysis methods, however some discrepancies can be observed. For instance, SUVR 80-100 has a generally noisier appearance and exhibits relatively higher signal in white matter than either of the kinetic analysis methods, a phenomenon most prominent in the control and TBI subjects. Conversely, signal in the basal ganglia is reduced in the SUVR 80-100 images as compared to maps obtained by Logan regression methods; similar patterns are present elsewhere, notably in occipital lobe of one MCI subject (S8) and in the frontal cortex of the other (S9).
--Insert Figure 6 here--
DISCUSSION
There has been a great effort toward the development of PET imaging agents for tau pathology due to the implication of tau in neurodegenerative diseases such as AD and TBI. F-T807 using metabolite corrected arterial input functions and dynamic PET imaging data. Herein, we evaluate subjects who present a range of 18 F-T807 uptake in order to properly assess different methods for quantification and to provide a preliminary analysis of simplified reference region based methods.
F-T807 In Blood
Radioactivity concentration in whole blood demonstrated rapid clearance with approximately 4% of the initial peak radioactivity present at 20 minutes post injection. Nonpolar radioactive metabolites detected using radio-HPLC were minimal. Furthermore, high intersubject consistency was found in 18 F-T807 metabolism and 18 F-T807 breakdown resulted in primarily polar metabolites. For this analysis, we found a group %PP function to be adequate by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from due to the high similarity in 18 F-T807 metabolism between subjects as the group %PP vs subject specific %PP correction resulted in highly concordant estimates of V T as shown in Supplemental Figure 4 0.99, 1.02 0.09, 0.0001 .
CB As A Reference Region
For simplified quantification methods beyond SUV, a reference region void of radiotracer target is necessary to provide a surrogate for the arterial input function. Of the regions examined in this work, the CB showed the lowest variability in V T and the lowest overall V T . Additionally, the CB showed fast wash-in and fast clearance resulting in low overall specific binding of 18 F-T807. In the control and TBI subjects, some regions exhibited DVR values < 1, however, regional DVR in MCI subjects were ≥ 1. Other potential reference regions examined in this work included parts of the brainstem comprising of the pons and medulla, however, high variability in total volume of distribution was found in these areas. This preliminary analysis supports the use of the cerebellum as the most appropriate reference region. Due to the particular staging of tau in Alzheimer's disease, we do not anticipate the cerebellum will comprise of significant tau deposition (17, 31, 32) . Subjects with TBI on the other hand could potentially present with tau in a less predictable manner. Ultimately, a larger study set will be required to fully validate the cerebellum as a reference region in AD subjects and subjects with TBI.
Simplified Approaches For Quantification Of
18
F-T807 Uptake
We examined simplified approaches for quantification of As the parametric images in Figure 6 indicate, 18 F-T807 uptake can be quantified reliably using graphical methods or SUVR. Images of SUVR were the lowest quality with apparent uptake in white matter that was not observed in the V T or DVR maps, however, SUVR seemed to be adequate for delineation and estimation of relative uptake of 18 F-T807.
Overall, distribution of 18 F-T807 in the control subject was generally uniform with no cortical areas expressing high distribution. Although not explicitly examined in this work, intersubject heterogeneity in uptake was observed in subcortical areas, e.g., the thalamus and putamen. Similar off target binding results have been observed (35) . In addition, our previous autoradiography work demonstrated off target binding to neuromelanin and melanin containing cells as well as hemorrhagic lesions (17) . Further examination of this off-target subcortical binding is warranted. The subject with a severe TBI due to an automobile accident expressed one region of very high uptake protruding from the posterior regions of the corpus callosum into the posterior cingulate gyrus possibly as a result of brain injury. Finally, the two MCI subjects demonstrated different distributions in uptake. S8 had highest uptake in the occipital regions. Subject S9 on the other hand demonstrated high 18 F-T807 uptake in areas associated with staging of tau in Alzheimer's disease (31) including temporal, parietal, posterior cingulate, and precuneus regions.
Study Limitations
This work included some limitations including no test-retest data. However, we observed low variability in blood data and cerebellar V T across subjects indicating test-retest would also be low. Use of a groupwise 18 F-T807 metabolism correction is a limitation and a full examination of intersubject variability in 18 F-T807 metabolism would be helpful to determine if there are differences between groups (MCI, TBI, and controls). Additionally, we only examined tauopathies related to MCI subjects and subjects with history of brain injury. A thorough investigation of 18 F-T807 kinetics in subjects with related tauopathies (e.g., frontotemporal dementia) will be necessary to determine the 18 F-T807 kinetic properties found in this work translate to other tau-related diseases. Even though for most subjects a two-tissue reversible model was preferred based on AIC, we found preference for the irreversible model in our TBI subjects. A full examination of 18 F-T807 kinetics in TBI subjects with a range of binding is needed to investigate this apparent discrepancy. Finally, our overall subject number was low, however, the subjects examined in this work had a wide range of dynamic 
CONCLUSION
18
F-T807 showed low intersubject variability in metabolism rate and overall rapid clearance in plasma. Two-tissue reversible compartmental modeling using 18 F-T807 arterial input function resulted in close agreement with linearized methods of V T estimation using both Logan (26) and MA1 (27) . The cerebellum exhibited properties required for use as a reference region in place of arterial sampling. These initial results show promise for a simplified reference region based protocol negating arterial sampling and using late static imaging with the goal of shorter scan times. Reference region based methods of quantification including Logan DVR with a t*=55 minutes and SUVR from 80-100 minutes tracked closely with compartmental modeling based outcome measures using arterial plasma input functions. Lastly, these results demonstrate 18 F-T807 possesses the properties necessary for quantification of tau using PET imaging. Further studies will be needed to fully characterize the use of the cerebellum as a valid reference region in a heterogenous population. by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from
